Clinical Characteristics and Outcomes of Rome <scp>IV</scp> Diarrhea‐Predominant Irritable Bowel Syndrome and Functional Diarrhea Prescribed With Ondansetron: A Real‐World Study
When used in clinical practice, 8 mg/day of ondansetron is associated with a reduction in bowel frequency and an improvement in fecal consistency in approximately two-thirds of patients with IBS-D and FDr.
Authors
- Caterina Sbarigia (ORCID: https://orcid.org/0009-0009-9267-9471)
- Christian Lambiase (ORCID: https://orcid.org/0000-0002-9565-5039)
- Robert E. Spiller (ORCID: https://orcid.org/0000-0001-6371-4500)
- Abdulsalam Aliyu (ORCID: https://orcid.org/0000-0002-7326-0917)
- Maura Corsetti (ORCID: https://orcid.org/0000-0003-2957-4684)
- Mohsin F. Butt (ORCID: https://orcid.org/0000-0003-0859-6470)
Institutions
- University of Pisa (IT)
- NIHR Nottingham Digestive Diseases Biomedical Research Unit (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- Sapienza University of Rome (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- Neurogastroenterology & Motility
- Published
- 2025-11-02
- DOI
- https://doi.org/10.1111/nmo.70193
- Citations
- 2
- Primary Topic
- Gastrointestinal motility and disorders
- Type
- article
- Field-Weighted Citation Impact
- 3.62